We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

The Role of Cocaine in the Etiology of Buerger Disease Is Questionable—Reply

Victor J. Marder, MD; Ingo K. Mellinghoff, MD
Arch Intern Med. 2001;161(3):486. doi:.
Text Size: A A A
Published online


In reply

The comments of Dr Bozkurt are noted, namely, that our patient does not fit the diagnostic criteria for Buerger disease according to the publication by Shionoya.1 Dr Bozkurt also points out that his review of hospital records of 258 such patients failed to reveal even a single case of cocaine addiction. We are pleased that our report has stimulated his efforts, since the proposal and hypothesis that we generated were meant to reevaluate the clinical entity and genesis of Buerger disease. Use of a table of criteria to diagnose a disease the distinction of which is questioned does not serve to contradict the question itself. Furthermore, we did not suggest that addiction to cocaine is a progenitor of the disease, but merely that the use of cocaine could predispose to vascular occlusive disease that could mimic Buerger disease. One cannot rule out temporal exposure to cocaine by failing to find a diagnosis of cocaine addiction in a patient's chart. We wholeheartedly agree with his final statement that "the significance of cocaine in the etiology of Buerger disease is at best controversial," since it is a novel concept, proposed more than 90 years after the original description.2

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview





February 12, 2001
Victor J. Marder, MD; Ingo K. Mellinghoff, MD
Arch Intern Med. 2001;161(3):486. doi:.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Cocaine and arsenic-induced Raynaud's phenomenon. Clin Rheumatol 2002;21(4):343-4.
[Nonatherosclerotic coronary artery disease]. Nihon Rinsho 2007;Suppl 5 Pt 2():228-33.